332 related articles for article (PubMed ID: 27539899)
1. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
4. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
Takebe H; Nishigori C; Tatsumi K
J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
[TBL] [Abstract][Full Text] [Related]
5. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
Kraemer KH; Lee MM; Andrews AD; Lambert WC
Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
10. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
11. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
[TBL] [Abstract][Full Text] [Related]
13. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
Lambert WC; Lambert MW
Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
[TBL] [Abstract][Full Text] [Related]
14. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
15. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
17. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
18. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
Bhutto AM; Shaikh A; Nonaka S
Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826
[TBL] [Abstract][Full Text] [Related]
19. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
[TBL] [Abstract][Full Text] [Related]
20. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
